CD8A and lung carcinoma: The activation of dendritic cells and their release of type I interferon after irradiation is also critical in CD8+ T cell activity and treatment efficacy in mouse colon carcinoma (MC38), lung carcinoma (LLC), and melanoma models (B16F10) (95, 96).